Paragon Biosciences Emalex Capital, Inc.

Form D Filings

Location
Chicaco, IL
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001749990
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
3/25/2025 Equity $32,000,000 $217,000,000 $242,000,000 $25,000,000 5/18/2022 3/25/2025 D/A 000174999025000002
11/10/2022 Equity $0 $185,000,000 $250,000,000 $65,000,000 10/21/2022 11/9/2022 D/A 000174999022000003
11/4/2022 Equity $185,000,000 $185,000,000 $250,000,000 $65,000,000 10/21/2022 11/4/2022 D 000174999022000002
11/4/2022 Debt, Security to be Acquired $25,000,000 $25,000,000 $25,000,000 $0 5/18/2022 11/4/2022 D 000174999022000001
3/12/2021 Equity $35,000,010 $35,000,010 $35,000,010 $0 2/25/2021 3/12/2021 D 000174999021000001
3/12/2021 Equity $0 $35,000,010 $35,000,010 $0 2/25/2021 3/12/2021 D/A 000174999021000002
10/3/2019 Equity $37,423,356 $37,423,356 $37,423,356 $0 9/18/2019 10/3/2019 D 000174999019000001
12/7/2018 Equity $2,450,000 $9,375,000 $9,375,000 $0 7/31/2018 12/3/2018 D/A 000174999018000003
8/14/2018 Equity $6,925,000 $6,925,000 $6,925,000 $0 7/31/2018 8/12/2018 D 000174999018000002